Record title

Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study

Record identifier

TN_cdi_proquest_journals_2443871297

https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2443871297

Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study

About this item

Full title

Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study

Publisher

England: Elsevier Ltd

Journal title

The Lancet (British edition), 2020, Vol.396 (10254), p.839-852

Record Identifier

TN_cdi_proquest_journals_2443871297

Language

English

Formats

Publication information

Publisher

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2443871297

Permalink

https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2443871297

Other Identifiers

ISSN

E-ISSN

DOI

How to access this item